The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
Patients suffering from chronic obstructive pulmonary disease (COPD) clinically manifest airway mucus hypersecretion as sputum expectoration and cough. Evidence accumulated in the past decade has shown that the cholinergic system not only regulates airway smooth muscle contraction but also the activ...
Main Authors: | Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute, Paola Rogliani |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2022-05-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/31/164/210196.full |
Similar Items
-
Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment
by: Binay Kumar Shah, et al.
Published: (2023-01-01) -
Sex differences in adult asthma and COPD therapy: a systematic review
by: Paola Rogliani, et al.
Published: (2022-08-01) -
Effects of Shiwei Longdanhua formula on LPS induced airway mucus hypersecretion, cough hypersensitivity, oxidative stress and pulmonary inflammation
by: Liu Wei, et al.
Published: (2023-07-01) -
Discovery of a drug to treat airway mucus hypersecretion
by: Burton F. Dickey, et al.
Published: (2022-08-01) -
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
by: Maria Gabriella Matera, et al.
Published: (2024-02-01)